Let’s live longer! Or not?
While several media outlets covered the unveiling of Unity Biotechnology, a company “designing therapeutics that prevent, halt or reverse numerous diseases of aging,” a debate was going on live stream if lifespans are already long enough.
Coverage of Unity Bio:
- Unity Biotechnology Launches with a Focus on Preventing and Reversing Diseases of Aging (press release)
- Buck Institute for Research on Aging Supports Launch of Incubator Company Focused on Age-Related Diseases (press release)
- Backed by a lineup of marquee VCs, Unity Biotechnology tackles the hard science of aging (FierceBiotech)
- Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest (Xconomy)
- Mayo Clinic Taps Silicon Valley to Help People Age Gracefully (Fortune)
- Look out, Calico — this startup is taking a killer approach to aging (SF Business Times)
From caption of video/page:
“What if we didn’t have to grow old and die? The average American can expect to live for 78.8 years, an improvement over the days before clean water and vaccines, when life expectancy was closer to 50, but still not long enough for most of us. So researchers around the world have been working on arresting the process of aging through biotechnology and finding cures to diseases like Alzheimer’s and cancer. What are the ethical and social consequences of radically increasing lifespans? Should we accept a “natural” end, or should we find a cure to aging?” Full feature
Also: How old is too old? A debate on toying with the human life span (STAT News)